Figure 2.
CDDP resistant OS cells showed greater migration and invasion capability. The in vitro migration of MG-63 (a) and U2OS (b) cells and their corresponding CDDP resistant cells were analyzed by use of wound healing assay (left) and quantitatively analyzed (right); (c) The in vitro invasion of MG-63 and U2OS cells and their corresponding CDDP resistant cells were analyzed by transwell assay for 24 h; (d) The migration markers of cancer cells were analyzed by use of western blot analysis. Data were presented as means ± SD of three independent experiments. ** p < 0.01 compared with control.